Ten-year-old Habiba lives with Type 1 Diabetes and needs to inject insulin twice every day. She was taught by MSF to inject herself and carries her insulin home, storing it in a portable cooler. Photo credit: Paul Odongo/MSF
Letter |

Open letter to Novo Nordisk on barriers to accessing diabetes medicines

DIABETES
Letter to Novo Nordisk
Report Cover Image
Photo credit: Paul Odongo/MSF

MSF sent this open letter to the CEOs of Novo Nordisk and Novo Nordisk Foundation highlighting the harmful consequences of their approach to the supply and pricing of insulin, and urging action for greater access to these medicines for people living with diabetes.

UPDATE, 11 November 2024: Novo Nordisk responded on 11 October 2024 with this reply letter, which we have marked up with our comments.

Read, watch, share